De Ceunynck Radiotherapy

Active

Public limited companyfounded 2017active for 9 yearsKontichsesteenweg 36, 2630 Aartselaar, BelgiumKBO/BCE: BE 0680.604.062

From the official registers: KBO 8 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

The computed 12-month bankruptcy probability of De Ceunynck Radiotherapy is 5.8% (elevated). The 2025 annual accounts show negative equity (-€2.0m) and a net result of -€446,329. Equity is shrinking by about 48% per year across the filed financial years. Its solvency ranks better than 5% of 93 sector peers (NACE 21, financial year 2025). The company has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow Report Compare

De Ceunynck RadiotherapyActiveChecked score 34/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 28-08-2017 Normal situation
Legal form: Public limited company
Registered office: Kontichsesteenweg 36, 2630 Aartselaar
Activity: Manufacture of basic pharmaceutical products and pharmaceutical preparations NACE 21209and 4 others
Establishment unit: 2.267.531.485 2630 Aartselaar, since 28-08-2017
Financial year end: 31 December
Peppol: Reachable since 14-11-2025

Company details

Who decides

Board

Peter DejongeManaging director
De Ceunynck ErikDirector

Shareholders

E & J99%annual accounts 2025

Board & ownership

How it is doing

34 Weak Checked score 2025

Bankruptcy probabilitywithin 12 months: 5.8%

Annual accounts 2025

Gross margin: -€33,632
Loss: €446,329; ▲ 11.5%
Equity: -€2.0m; ▼ 27.9%
Total assets: €477,215; ▼ 24.9%
Staff: 2 FTE; ▼ 20.0%

2025 accounts filed 91 days late

Filed on 30-10-2026at the National Bank

Financials

Why 34raises riskLoss of €446,329, the second in a row (financial year 2025)Negative equity -€2.0mLast filed accounts filed 91 days late; 2 of the last 3 lateFigures for financial year 2025 (filed 30-10-2026)Show the evidence

Checked score

Score 2025

34 / 100

Weak

Probability in this band: 4.2% to 15.0%

Financially better than 16% of its sector peers (NACE 21, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Weak

Solvency 0=

equity -428.8% of total assets

Liquidity 18=

short-term debt 528.8% · cash 14.1%

Profitability 0=

return on assets -93.5%

Bankruptcy probability, 12 months

5.8% Elevated

0%0.5%1.5%4%10%≥ 25%

About 6 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.3% (153 companies, NACE 21, micro)

Last 24 months 11-2024: 4.5% 12-2024: 5.1%▲ +0.6 percentage points vs 11-2024 01-2025: 6.2%▲ +1.1 percentage points vs 12-2024 02-2025: 6.3%▲ +0.1 percentage points vs 01-2025 03-2025: 6.3%● unchanged vs 02-2025 04-2025: 5.7%▼ -0.6 percentage points vs 03-2025 05-2025: 5.7%● unchanged vs 04-2025 06-2025: 5.6%▼ -0.1 percentage points vs 05-2025 07-2025: 5.6%● unchanged vs 06-2025 08-2025: 6.8%▲ +1.2 percentage points vs 07-2025highest value 09-2025: 3.9%▼ -2.9 percentage points vs 08-2025lowest value 10-2025: 4.2%▲ +0.3 percentage points vs 09-2025 11-2025: 4.2%● unchanged vs 10-2025 12-2025: 4.2%● unchanged vs 11-2025 01-2026: 4.4%▲ +0.2 percentage points vs 12-2025 02-2026: 4.4%● unchanged vs 01-2026 03-2026: 4.2%▼ -0.2 percentage points vs 02-2026 04-2026: 4.2%● unchanged vs 03-2026 05-2026: 4.2%● unchanged vs 04-2026 06-2026: 4.1%▼ -0.1 percentage points vs 05-2026 07-2026: 4.1%● unchanged vs 06-2026 08-2026: 4.6%▲ +0.5 percentage points vs 07-2026 09-2026: 4.7%▲ +0.1 percentage points vs 08-2026 10-2026: 5.8%▲ +1.1 percentage points vs 09-2026

No credit on open account

Liquidity insufficient (current ratio 0.16, compared with 0.25 in 2024, below 1; short-term debt: 528.8% and cash: 14.1% of total assets), and equity is negative.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 21, micro): better than 10% on solvency, 15% on liquidity, 13% on profitability and 25% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.

raises risk

Loss of €446,329, the second in a row (financial year 2025)

NBB · annual accounts

Negative equity -€2.0m

NBB · annual accounts

Last filed accounts filed 91 days late; 2 of the last 3 late

NBB · filings

Figures for financial year 2025 (filed 30-10-2026)

NBB · annual accounts

Negative equity

The 2025 annual accounts show negative equity and a net loss.

NBB · annual accounts 2025

Equity per financial year

1819202122232425

2018 to 2025 · latest year -€2.0m

2025 accounts filed 91 days late

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-10-2026, 91 days past the deadline. Measured on financial year 2023: of the companies more than 90 days late, 5.61% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers.

NBB · 8 filings

Deviation from the deadline

2025

91 days late

2024

29 days late

2023

337 days late

2022

247 days late

2021

89 days late

2020

61 days late

2019

91 days late

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 135 days after the deadline; the sector median (NACE 21) for financial year 2024 is 9 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 October (4 of the last 5 filed years within 156 days of that day).

Companies Code · seven months

Where today falls in the filing period

01-11-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

Key points

Risk: Negative equityfinancial year 2025: debts exceed assets -€2.0m View
Risk: 3 loss-making years in a rowloss financial year 2025 -€446,329 View
Caution: Among the weakest 5% on solvencysector median 48.4% · 93 companies -428.8% View
Caution: Equity fell in 2025from -€1.6m to -€2.0m ▼ 27.9% View

Documents

Key facts about De Ceunynck Radiotherapy

What is the company number of De Ceunynck Radiotherapy?: 0680.604.062. In Belgium the VAT number is the company number with BE in front: BE 0680.604.062.
Where is De Ceunynck Radiotherapy based?: The registered office is at Kontichsesteenweg 36, 2630 Aartselaar.Company details
What does De Ceunynck Radiotherapy do?: According to the KBO register, the main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21209).
What is the legal form of De Ceunynck Radiotherapy?: Public limited company (NV).
When was De Ceunynck Radiotherapy founded?: On 28-08-2017.
Is De Ceunynck Radiotherapy still active?: Yes, De Ceunynck Radiotherapy is an active enterprise in the KBO register.
How many employees does De Ceunynck Radiotherapy have?: On average 2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of De Ceunynck Radiotherapy?: The annual accounts for financial year 2025 state no turnover.
Is De Ceunynck Radiotherapy profitable?: In financial year 2025, De Ceunynck Radiotherapy made a loss of €446,329.
Where can I find the annual accounts of De Ceunynck Radiotherapy?: De Ceunynck Radiotherapy filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of De Ceunynck Radiotherapy due?: By 31-07-2027, for financial year 2026.Timeline